Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Agilon Health (AGL) Income from Non-Controlling Interests (2021 - 2024)

Agilon Health's Income from Non-Controlling Interests history spans 4 years, with the latest figure at $20000.0 for Q2 2024.

  • For Q2 2024, Income from Non-Controlling Interests rose 143.48% year-over-year to $20000.0; the TTM value through Mar 2025 reached $20000.0, up 117.54%, while the annual FY2024 figure was $50000.0, 124.15% up from the prior year.
  • Income from Non-Controlling Interests reached $20000.0 in Q2 2024 per AGL's latest filing, down from $30000.0 in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $115000.0 in Q3 2021 to a low of -$584000.0 in Q4 2021.
  • Average Income from Non-Controlling Interests over 4 years is -$54571.4, with a median of -$49000.0 recorded in 2023.
  • The largest YoY upside for Income from Non-Controlling Interests was 202.74% in 2022 against a maximum downside of 185.42% in 2022.
  • A 4-year view of Income from Non-Controlling Interests shows it stood at -$584000.0 in 2021, then surged by 85.79% to -$83000.0 in 2022, then skyrocketed by 38.55% to -$51000.0 in 2023, then surged by 139.22% to $20000.0 in 2024.
  • Per Business Quant, the three most recent readings for AGL's Income from Non-Controlling Interests are $20000.0 (Q2 2024), $30000.0 (Q1 2024), and -$51000.0 (Q4 2023).